Ask AI
ProCE Banner Activity

Answering Your Questions: Pain Management Strategies and Best Practices

Text Module

Get expert answers to frequently asked questions compiled from question and answer sessions in our Opioid REMS/Pain Management workshop series. New questions and responses will be added as future discussion sessions occur.

Released: January 19, 2024

Share

Provided by

Provided by Clinical Care Options, LLC, and in partnership with Alliance to Advance Comprehensive Integrative Pain Management, American Academy of Physical Medicine and Rehabilitation and Practicing Clinicians Exchange, and ProCE

ProCE Banner

Supporters

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Opioid Analgesic REMS Program Companies

Partners

Alliance to Advance Comprehensive Integrative Pain Management

ProCE Banner

American Academy of Physical Medicine and Rehabilitation

ProCE Banner

Practicing Clinicians Exchange, LLC

ProCE Banner

ProCE, LLC

ProCE Banner

Faculty Disclosure

Primary Author

Jeremy Adler, DMSc, PA-C

Senior Pain Management Physician Associate
Pacific Pain Medicine Consultants
Encinitas, CA

Samantha M. Catanzano, PharmD, BCPP

Clinical Associate Professor
Division of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
Austin, Texas

Samantha M. Catanzano, PharmD, BCPP, has no relevant financial relationships to disclose.

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, FAANP

Adult Nurse Practitioner, Pain Management and Anesthesia
Stanford Health Care
Redwood City, California

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, FAANP: consultant/advisor/speaker: Axsome, Pfizer, Tonix, Vertex.

Michael Sprintz, DO, DFASAM

Medical Director, Substance Abuse and Mental Health IOP Programs
The Lovett Behavioral Health Group
Houston, Texas

Michael Sprintz, DO, DFASAM: owner: Advanced Genomics Lab; consultant/advisor/speaker: Accu Reference Medical Lab, Patch Technologies, Spark BioMedical, Tafalgie; stock/stock options: Affect Therapeutics, Bridge Therapeutics.

Michael Weaver, MD, DFASAM

Professor, Department of Psychiatry and Behavioral Sciences
Medical Director, Center for Neurobehavioral Research on Addiction
McGovern Medical School
The University of Texas Health Science Center at Houston
Houston, Texas

Michael Weaver, MD, DFASAM: researcher: Novo Nordisk.